Premarket analyst action - healthcare

  • Thermo Fisher (NYSE:TMO), Danaher (NYSE:DHR), Illumina (NASDAQ:ILMN), Agilent (NYSE:A) and Qiagen (NASDAQ:QGEN) all initiated with Outperform rating by Evercore ISI.
  • Cerner (NASDAQ:CERN), athenahealth (NASDAQ:ATHN) and Health Management Systems (NASDAQ:HMSY) all initiated with Neutral ratings by Citigroup.
  • Nightstar Therapeutics (NASDAQ:NITE) initiated with Buy rating and $40 (203% upside) price target by Chardan Capital.
  • Summit Therapeutics (NASDAQ:SMMT) initiated with Buy rating and $24 (115% upside) price target by SunTrust.
  • Sarepta Therapeutics (NASDAQ:SRPT) initiated with Buy rating and $75 (28% upside) price target by Janney.
  • Humana (NYSE:HUM) added to U.S. 1 List at BofA/Merrill Lynch.
  • IDEXX Labs (NASDAQ:IDXX) added to Select List at Stifel.
  • Hologic (NASDAQ:HOLX) upgraded to Buy by BofA/Merrill Lynch.
  • Edwards Lifesciences (NYSE:EW) upgraded to Overweight by Barclays.
  • CVS Health (NYSE:CVS) upgraded to Strong Buy by Raymond James.
  • NuVasive (NASDAQ:NUVA) upgraded to Buy with a $71 (16% upside) price target by Needham.
  • Zoetis (NYSE:ZTS) upgraded to Buy by Citigroup.
  • DaVita (NYSE:DVA) upgraded to Buy by BofA/Merrill Lynch.
  • Teva Pharmaceutical Industries (NYSE:TEVA) upgraded to Buy by Citigroup.
  • Quidel (NASDAQ:QDEL) upgraded to Buy by CL King.
  • Alexion Pharmaceuticals (NASDAQ:ALXN) downgraded to Outperform from Strong Buy by Raymond James.

Recommended For You

Comments (6)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.